H1B Salary Data

Home › Employers › China Med Device, LLC

China Med Device, LLC: H-1B salaries and sponsorship

China Med Device, LLC filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $60,000.

Applications (LCAs)3
Certified3
Employer addressCambridge, MA
H-1B dependent employerNo
Median offered salary$60,000
Middle half of salaries$60,000–$60,275
10th–90th percentile$60,000–$60,440

Does China Med Device, LLC sponsor H-1B visas?

China Med Device, LLC filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Apr 1, 2025. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Marketing Specialist2$60,000
Consultant Assistant to Regulatory and Clinical Affairs1$60,550

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20231$60,000
FY20241$60,000
FY20251$60,550

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Consultant Assistant to Regulatory and Clinical Affairs$60,550
Level I
Bridgewater, NJApr 1, 2025Oct 1, 2025Certified
Marketing Specialist$60,000
Level I
Cambridge, MAAug 18, 2024Sep 16, 2024Certified
Marketing Specialist$60,000
Level I
Cambridge, MAAug 24, 2023Sep 16, 2023Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).